Search

everythinglearnresearchcommunity

for

Search:↓

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Targeted cancer therapies often cause serious skin problems that need careful management.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Medications can cause eye problems, so regular eye check-ups are important.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

The conclusion is that skin, mucous, and eye problems after Stevens-Johnson syndrome and Lyell syndrome significantly affect patients' lives, highlighting the need for comprehensive care and eye check-ups.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Erlotinib can cause excessive eyelash growth.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

ATP helps prevent skin damage from vandetanib by reducing stress.

Cancer survivors need better skin care to improve their quality of life.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Panitumumab can cause excessive ear hair growth.